2019-02-21: HbA1c net FS – The Future of Diabetes Management

DiaSys now offers a new enzymatic HbA1c assay - HbA1c net FS - for diagnosis and monitoring of diabetes. This innovative test is setting new standards for accuracy through its outstanding specificity and excellent precision. HbA1c net FS delivers results equivalent to HPLC. Interferences by hemoglobin variants or other blood components are minimized compared to available tests in the market e.g. HPLC, immunoturbidimetric or immuninhibition methods. DiaSys’ HbA1c net FS is standardized against the IFCC reference method and traceable to DCCT/NGSP. Fully automated handling on clinical chemistry platforms, including onboard hemolysis, allows convenient management of your daily challenges. HbA1c net FS complements the DiaSys diabetes portfolio and is a powerful tool for consistent diagnosis and monitoring of diabetes. Further information is available on: www.hba1cnet.com